Modeling human neurodegeneration with iPSCs: opportunities, limitations, and the challenge of aging
A framework matching model systems to biological questions is proposed, improving mechanistic understanding and therapeutic development and addressing the aging problem: reprogramming erases epigenetic signatures of donor aging, removing the cellular context in which late-onset sporadic neurodegeneration emerges.